The point of care testing market for TC tests is expected to develop at a 7.1% CAGR through 2027, owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. The First Response kit, for example, is a quick pregnancy test that provides a response in 60 seconds. Accu-Chek active blood glucose metre kits also give customers with readings in 5 seconds, boosting market demand.



Get Your Sample Today:




Market  Analysis and Insights 


POC tests are not as highly preferred as central laboratory tests because of low volume and high cost. This puts additional strain on the billing system, which must give distinct codes for POC tests. This might result in billing errors by inexperienced or newly hired employees, as well as failure to enter data into the data management system due to mismatched test codes. Point-of-care testing, which is defined as testing that may be done in close proximity to the patient and allows a medical choice to be taken right away based on the results and monitoring. point-of-care testing (POCT), also known as with-patient testing, allows doctors to assess accurate real-time, lab-quality diagnostic results in minutes rather than hours. It guarantees that patients get the most effective and efficient care possible, whenever and wherever they need it.


 Buy Now Access Full Report:-


Asia-Pacific Point-of-Care Testing (POCT) Market Scope


The point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


·       Glucose Monitoring

·       Strips

·       Meters

·       Lancets

·       Cardiometabolic testing

·       Cardiac marker testing

·       hsTnl

·       BNP

·       D-dimer

·       CK-MB

·       Myoglobin

·       Others

·       Blood gas/electrolytes testing

·       HBA1C testing

·       Infectious disease testing

·       Influenza testing

·       HIV testing

·       Hepatitis C testing

·       Sexually Transmitted Disease (STD) testing

·       Healthcare-Associated Infection (HAI) testing

·       Respiratory infection testing

·       Tropical disease testing

·       Other infectious diseases testing

·       Coagulation testing

·       PT/INR testing

·       Activated Clotting Time (ACT/APTT) testing

·       Pregnancy and fertility testing

·       Pregnancy testing

·       Fertility testing

·       Tumor/Cancer marker testing

·       Urinalysis testing

·       Cholesterol testing

·       Hematology testing

·       Drugs-of-abuse testing

·       Fecal occult testing

·       Others


·       Lateral flow assays

·       Dipsticks

·       Microfluidics

·       Molecular diagnostics

·       Immunoassays

·       Agglutination assays

·       Flow-through

·       Solid phase

·       Biosensors


·       OTC testing

·       Prescription-based testing




Asia-Pacific Point-of-Care Testing (POCT) Market Country Level Analysis


China is expected to dominate the market because point-of-care testing (POCT) products in China have a massive application space in the fields of hospital operation, emergency department, intensive care, chronic disease prevention and control, public health emergencies, county-level medical institution construction, and new rural supportive medical care.

The point-of-care testing (POCT) market is analysed and market size insights and trends are provided by country, product, technology, prescription, application end-user and distribution channel as referenced above. The countries covered in the point-of-care testing (POCT) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 



Browse The Table of Contents And List of Figures:


Major TOC of the Asia-Pacific Point-of-Care Testing (POCT) Market Report

Chapter One:






Competitive Landscape and Asia-Pacific Point-of-Care Testing (POCT) Market Share Analysis


The point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point-of-care testing (POCT) market.

  Some of the major players operating in the negative pressure wound therapy devices market are

·       Abbott (U.S)

·       F. Hoffmann-La Roche Ltd (Switzerland)

·       BD (U.S)

·       Siemens Healthcare Private Limited (Germany)

·       Bio-Rad Laboratories, Inc. (U.S)

·       Danaher (U.S)

·       Sekisui Diagnostics (U.S)

·       Trinity Biotech (Ireland)

·       bioMérieux (France)

·       EKF Diagnostics (Germany)

·       AccuBioTech Co., Ltd. (China)

·       Instrumentation Laboratory (U.S)

·       Beckman Coulter, Inc. (U.S)

·       PTS Diagnostics (U.S)

·       Nova Biomedical (U.S)

·       Chembio Diagnostics, Inc. (U.S)

·       Quidel Corporation (U.S)

·       Sienco, Inc (U.S)



 About Us:

Data Bridge Market  Research set forth itself as an unconventional and neoteric Market  research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market



Data Bridge Market  Research

Tel: +1-888-3895-2818

Email: Sopan.gedam@databridgeMarket


Browse Related Reports@

North America Dental Lasers Market

Europe Dental Lasers market

Asia-Pacific Dental Lasers market